Blog

Vertex taps California startup for $700M gene-editing deal

vertex-02900xx3600-5388-0-376

Vertex has developed cystic fibrosis therapies and is working with other partners on CRISPR-Cas9 systems as well as messenger RNA, or MRNA, therapies with Moderna Inc.

Read More